img

Global Microsphere Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Microsphere Drug Market Insights, Forecast to 2034

Microsphere drug refers to a drug delivery system that uses micron-scale spherical particles as drug carriers, and wraps and encapsulates drug substances inside or on the surface of drug microspheres. By controlling the release rate and directional delivery of drug microspheres, this drug delivery system can achieve sustained drug release, reduce drug dose, improve drug stability, and regulate drug distribution and efficacy in vivo.
Market Analysis and InsightsGlobal Microsphere Drug Market
Global Microsphere Drug market is expected to reach to US$ 9100 million in 2024, with a positive growth of %, compared with US$ 8800 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Microsphere Drug industry is evaluated to reach US$ 11720 million in 2034. The CAGR will be 4.3% during 2024 to 2034.
Globally, Microsphere Drug key companies include Johnson & Johnson, Takeda, Novartis, Ipsen Biopharmaceuticals, Inc, Ferring Pharmaceuticals, AstraZeneca, Pfizer, AbbVie and Beijing Biote Pharmaceutical Co.,Ltd, etc. Johnson & Johnson, Takeda, Novartis are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Microsphere Drug were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034 and the share will be % in 2034. Moreover, China, plays a key role in the whole Microsphere Drug market and estimated to attract more attentions from industry insiders and investors.
Microsphere Drug can be divided into Leuprolide Microspheres, Risperidone Microspheres, Octreotide Microspheres and Triptorelin Microspheres, etc. Leuprolide Microspheres is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2034.
Microsphere Drug is widely used in various fields, such as Cancer, Mental Illness and Other,, etc. Cancer provides greatest supports to the Microsphere Drug industry development. In 2022, global % revenue of Microsphere Drug went into Cancer filed and the proportion will reach to % in 2034.
Report Covers
This report presents an overview of global Microsphere Drug market from 2018 to 2034, aiming to help readers to get a comprehensive understanding of global Microsphere Drug market with multiple angles. Items like regional revenue from 2018 to 2034 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2034 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Johnson & Johnson
Takeda
Novartis
Ipsen Biopharmaceuticals, Inc
Ferring Pharmaceuticals
AstraZeneca
Pfizer
AbbVie
Beijing Biote Pharmaceutical Co.,Ltd
Livzon Pharmaceutical Group
Luye Pharma
Grand Pharmaceutical Group Limited
Segment by Type
Leuprolide Microspheres
Risperidone Microspheres
Octreotide Microspheres
Triptorelin Microspheres
other

Segment by Application


Cancer
Mental Illness
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2034
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2034 globally
Chapter 5Product revenue analysis by application from 2018 to 2034 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2034 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2034
Chapter 7Product revenue analysis by type and application from 2018 to 2034 in Europe. Product revenue analysis of each country in Europe from 2018 to 2034
Chapter 8Product revenue analysis by type and application from 2018 to 2034 in China. Product revenue analysis of China from 2018 to 2034
Chapter 9Product revenue analysis by type and application from 2018 to 2034 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2034
Chapter 10Product revenue analysis by type and application from 2018 to 2034 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2034.
Chapter 11Companies’ outline, covering company’s basic information, major business, Microsphere Drug introduction, etc. Microsphere Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12QYResearch’s Conclusions of Microsphere Drug
Chapter 13Methodology and Data Sources adopted by QYResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microsphere Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Leuprolide Microspheres
1.2.3 Risperidone Microspheres
1.2.4 Octreotide Microspheres
1.2.5 Triptorelin Microspheres
1.2.6 other
1.3 Market by Application
1.3.1 Global Microsphere Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Cancer
1.3.3 Mental Illness
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microsphere Drug Market Perspective (2018-2034)
2.2 Global Microsphere Drug Growth Trends by Region
2.2.1 Microsphere Drug Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Microsphere Drug Historic Market Size by Region (2018-2024)
2.2.3 Microsphere Drug Forecasted Market Size by Region (2024-2034)
2.3 Microsphere Drug Market Dynamics
2.3.1 Microsphere Drug Industry Trends
2.3.2 Microsphere Drug Market Drivers
2.3.3 Microsphere Drug Market Challenges
2.3.4 Microsphere Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Microsphere Drug by Players
3.1.1 Global Microsphere Drug Revenue by Players (2018-2024)
3.1.2 Global Microsphere Drug Revenue Market Share by Players (2018-2024)
3.2 Global Microsphere Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Microsphere Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Microsphere Drug Market Concentration Ratio
3.4.1 Global Microsphere Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microsphere Drug Revenue in 2022
3.5 Global Key Players of Microsphere Drug Head office and Area Served
3.6 Global Key Players of Microsphere Drug, Product and Application
3.7 Global Key Players of Microsphere Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Microsphere Drug Breakdown Data by Type
4.1 Global Microsphere Drug Historic Market Size by Type (2018-2024)
4.2 Global Microsphere Drug Forecasted Market Size by Type (2024-2034)
5 Microsphere Drug Breakdown Data by Application
5.1 Global Microsphere Drug Historic Market Size by Application (2018-2024)
5.2 Global Microsphere Drug Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Microsphere Drug Market Size (2018-2034)
6.2 North America Microsphere Drug Market Size by Type
6.2.1 North America Microsphere Drug Market Size by Type (2018-2024)
6.2.2 North America Microsphere Drug Market Size by Type (2024-2034)
6.2.3 North America Microsphere Drug Market Share by Type (2018-2034)
6.3 North America Microsphere Drug Market Size by Application
6.3.1 North America Microsphere Drug Market Size by Application (2018-2024)
6.3.2 North America Microsphere Drug Market Size by Application (2024-2034)
6.3.3 North America Microsphere Drug Market Share by Application (2018-2034)
6.4 North America Microsphere Drug Market Size by Country
6.4.1 North America Microsphere Drug Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America Microsphere Drug Market Size by Country (2018-2024)
6.4.3 North America Microsphere Drug Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Microsphere Drug Market Size (2018-2034)
7.2 Europe Microsphere Drug Market Size by Type
7.2.1 Europe Microsphere Drug Market Size by Type (2018-2024)
7.2.2 Europe Microsphere Drug Market Size by Type (2024-2034)
7.2.3 Europe Microsphere Drug Market Share by Type (2018-2034)
7.3 Europe Microsphere Drug Market Size by Application
7.3.1 Europe Microsphere Drug Market Size by Application (2018-2024)
7.3.2 Europe Microsphere Drug Market Size by Application (2024-2034)
7.3.3 Europe Microsphere Drug Market Share by Application (2018-2034)
7.4 Europe Microsphere Drug Market Size by Country
7.4.1 Europe Microsphere Drug Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Microsphere Drug Market Size by Country (2018-2024)
7.4.3 Europe Microsphere Drug Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Microsphere Drug Market Size (2018-2034)
8.2 China Microsphere Drug Market Size by Type
8.2.1 China Microsphere Drug Market Size by Type (2018-2024)
8.2.2 China Microsphere Drug Market Size by Type (2024-2034)
8.2.3 China Microsphere Drug Market Share by Type (2018-2034)
8.3 China Microsphere Drug Market Size by Application
8.3.1 China Microsphere Drug Market Size by Application (2018-2024)
8.3.2 China Microsphere Drug Market Size by Application (2024-2034)
8.3.3 China Microsphere Drug Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Microsphere Drug Market Size (2018-2034)
9.2 Asia Microsphere Drug Market Size by Type
9.2.1 Asia Microsphere Drug Market Size by Type (2018-2024)
9.2.2 Asia Microsphere Drug Market Size by Type (2024-2034)
9.2.3 Asia Microsphere Drug Market Share by Type (2018-2034)
9.3 Asia Microsphere Drug Market Size by Application
9.3.1 Asia Microsphere Drug Market Size by Application (2018-2024)
9.3.2 Asia Microsphere Drug Market Size by Application (2024-2034)
9.3.3 Asia Microsphere Drug Market Share by Application (2018-2034)
9.4 Asia Microsphere Drug Market Size by Region
9.4.1 Asia Microsphere Drug Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia Microsphere Drug Market Size by Region (2018-2024)
9.4.3 Asia Microsphere Drug Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Microsphere Drug Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Microsphere Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Microsphere Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Microsphere Drug Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Microsphere Drug Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Microsphere Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Microsphere Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Microsphere Drug Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Microsphere Drug Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Microsphere Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Microsphere Drug Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Microsphere Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Microsphere Drug Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Microsphere Drug Introduction
11.1.4 Johnson & Johnson Revenue in Microsphere Drug Business (2018-2024)
11.1.5 Johnson & Johnson Recent Developments
11.2 Takeda
11.2.1 Takeda Company Details
11.2.2 Takeda Business Overview
11.2.3 Takeda Microsphere Drug Introduction
11.2.4 Takeda Revenue in Microsphere Drug Business (2018-2024)
11.2.5 Takeda Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Microsphere Drug Introduction
11.3.4 Novartis Revenue in Microsphere Drug Business (2018-2024)
11.3.5 Novartis Recent Developments
11.4 Ipsen Biopharmaceuticals, Inc
11.4.1 Ipsen Biopharmaceuticals, Inc Company Details
11.4.2 Ipsen Biopharmaceuticals, Inc Business Overview
11.4.3 Ipsen Biopharmaceuticals, Inc Microsphere Drug Introduction
11.4.4 Ipsen Biopharmaceuticals, Inc Revenue in Microsphere Drug Business (2018-2024)
11.4.5 Ipsen Biopharmaceuticals, Inc Recent Developments
11.5 Ferring Pharmaceuticals
11.5.1 Ferring Pharmaceuticals Company Details
11.5.2 Ferring Pharmaceuticals Business Overview
11.5.3 Ferring Pharmaceuticals Microsphere Drug Introduction
11.5.4 Ferring Pharmaceuticals Revenue in Microsphere Drug Business (2018-2024)
11.5.5 Ferring Pharmaceuticals Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Microsphere Drug Introduction
11.6.4 AstraZeneca Revenue in Microsphere Drug Business (2018-2024)
11.6.5 AstraZeneca Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Microsphere Drug Introduction
11.7.4 Pfizer Revenue in Microsphere Drug Business (2018-2024)
11.7.5 Pfizer Recent Developments
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Microsphere Drug Introduction
11.8.4 AbbVie Revenue in Microsphere Drug Business (2018-2024)
11.8.5 AbbVie Recent Developments
11.9 Beijing Biote Pharmaceutical Co.,Ltd
11.9.1 Beijing Biote Pharmaceutical Co.,Ltd Company Details
11.9.2 Beijing Biote Pharmaceutical Co.,Ltd Business Overview
11.9.3 Beijing Biote Pharmaceutical Co.,Ltd Microsphere Drug Introduction
11.9.4 Beijing Biote Pharmaceutical Co.,Ltd Revenue in Microsphere Drug Business (2018-2024)
11.9.5 Beijing Biote Pharmaceutical Co.,Ltd Recent Developments
11.10 Livzon Pharmaceutical Group
11.10.1 Livzon Pharmaceutical Group Company Details
11.10.2 Livzon Pharmaceutical Group Business Overview
11.10.3 Livzon Pharmaceutical Group Microsphere Drug Introduction
11.10.4 Livzon Pharmaceutical Group Revenue in Microsphere Drug Business (2018-2024)
11.10.5 Livzon Pharmaceutical Group Recent Developments
11.11 Luye Pharma
11.11.1 Luye Pharma Company Details
11.11.2 Luye Pharma Business Overview
11.11.3 Luye Pharma Microsphere Drug Introduction
11.11.4 Luye Pharma Revenue in Microsphere Drug Business (2018-2024)
11.11.5 Luye Pharma Recent Developments
11.12 Grand Pharmaceutical Group Limited
11.12.1 Grand Pharmaceutical Group Limited Company Details
11.12.2 Grand Pharmaceutical Group Limited Business Overview
11.12.3 Grand Pharmaceutical Group Limited Microsphere Drug Introduction
11.12.4 Grand Pharmaceutical Group Limited Revenue in Microsphere Drug Business (2018-2024)
11.12.5 Grand Pharmaceutical Group Limited Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Microsphere Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Leuprolide Microspheres
Table 3. Key Players of Risperidone Microspheres
Table 4. Key Players of Octreotide Microspheres
Table 5. Key Players of Triptorelin Microspheres
Table 6. Key Players of other
Table 7. Global Microsphere Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 8. Global Microsphere Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 9. Global Microsphere Drug Market Size by Region (2018-2024) & (US$ Million)
Table 10. Global Microsphere Drug Market Share by Region (2018-2024)
Table 11. Global Microsphere Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 12. Global Microsphere Drug Market Share by Region (2024-2034)
Table 13. Microsphere Drug Market Trends
Table 14. Microsphere Drug Market Drivers
Table 15. Microsphere Drug Market Challenges
Table 16. Microsphere Drug Market Restraints
Table 17. Global Microsphere Drug Revenue by Players (2018-2024) & (US$ Million)
Table 18. Global Microsphere Drug Revenue Share by Players (2018-2024)
Table 19. Global Top Microsphere Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microsphere Drug as of 2022)
Table 20. Global Microsphere Drug Industry Ranking 2021 VS 2022 VS 2024
Table 21. Global 5 Largest Players Market Share by Microsphere Drug Revenue (CR5 and HHI) & (2018-2024)
Table 22. Global Key Players of Microsphere Drug, Headquarters and Area Served
Table 23. Global Key Players of Microsphere Drug, Product and Application
Table 24. Global Key Players of Microsphere Drug, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Microsphere Drug Market Size by Type (2018-2024) & (US$ Million)
Table 27. Global Microsphere Drug Revenue Market Share by Type (2018-2024)
Table 28. Global Microsphere Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 29. Global Microsphere Drug Revenue Market Share by Type (2024-2034)
Table 30. Global Microsphere Drug Market Size by Application (2018-2024) & (US$ Million)
Table 31. Global Microsphere Drug Revenue Share by Application (2018-2024)
Table 32. Global Microsphere Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 33. Global Microsphere Drug Revenue Share by Application (2024-2034)
Table 34. North America Microsphere Drug Market Size by Type (2018-2024) & (US$ Million)
Table 35. North America Microsphere Drug Market Size by Type (2024-2034) & (US$ Million)
Table 36. North America Microsphere Drug Market Size by Application (2018-2024) & (US$ Million)
Table 37. North America Microsphere Drug Market Size by Application (2024-2034) & (US$ Million)
Table 38. North America Microsphere Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 39. North America Microsphere Drug Market Size by Country (2018-2024) & (US$ Million)
Table 40. North America Microsphere Drug Market Size by Country (2024-2034) & (US$ Million)
Table 41. Europe Microsphere Drug Market Size by Type (2018-2024) & (US$ Million)
Table 42. Europe Microsphere Drug Market Size by Type (2024-2034) & (US$ Million)
Table 43. Europe Microsphere Drug Market Size by Application (2018-2024) & (US$ Million)
Table 44. Europe Microsphere Drug Market Size by Application (2024-2034) & (US$ Million)
Table 45. Europe Microsphere Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 46. Europe Microsphere Drug Market Size by Country (2018-2024) & (US$ Million)
Table 47. Europe Microsphere Drug Market Size by Country (2024-2034) & (US$ Million)
Table 48. China Microsphere Drug Market Size by Type (2018-2024) & (US$ Million)
Table 49. China Microsphere Drug Market Size by Type (2024-2034) & (US$ Million)
Table 50. China Microsphere Drug Market Size by Application (2018-2024) & (US$ Million)
Table 51. China Microsphere Drug Market Size by Application (2024-2034) & (US$ Million)
Table 52. Asia Microsphere Drug Market Size by Type (2018-2024) & (US$ Million)
Table 53. Asia Microsphere Drug Market Size by Type (2024-2034) & (US$ Million)
Table 54. Asia Microsphere Drug Market Size by Application (2018-2024) & (US$ Million)
Table 55. Asia Microsphere Drug Market Size by Application (2024-2034) & (US$ Million)
Table 56. Asia Microsphere Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 57. Asia Microsphere Drug Market Size by Region (2018-2024) & (US$ Million)
Table 58. Asia Microsphere Drug Market Size by Region (2024-2034) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Microsphere Drug Market Size by Type (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Microsphere Drug Market Size by Type (2024-2034) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Microsphere Drug Market Size by Application (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Microsphere Drug Market Size by Application (2024-2034) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Microsphere Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 64. Middle East, Africa, and Latin America Microsphere Drug Market Size by Country (2018-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Microsphere Drug Market Size by Country (2024-2034) & (US$ Million)
Table 66. Johnson & Johnson Company Details
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Microsphere Drug Product
Table 69. Johnson & Johnson Revenue in Microsphere Drug Business (2018-2024) & (US$ Million)
Table 70. Johnson & Johnson Recent Developments
Table 71. Takeda Company Details
Table 72. Takeda Business Overview
Table 73. Takeda Microsphere Drug Product
Table 74. Takeda Revenue in Microsphere Drug Business (2018-2024) & (US$ Million)
Table 75. Takeda Recent Developments
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis Microsphere Drug Product
Table 79. Novartis Revenue in Microsphere Drug Business (2018-2024) & (US$ Million)
Table 80. Novartis Recent Developments
Table 81. Ipsen Biopharmaceuticals, Inc Company Details
Table 82. Ipsen Biopharmaceuticals, Inc Business Overview
Table 83. Ipsen Biopharmaceuticals, Inc Microsphere Drug Product
Table 84. Ipsen Biopharmaceuticals, Inc Revenue in Microsphere Drug Business (2018-2024) & (US$ Million)
Table 85. Ipsen Biopharmaceuticals, Inc Recent Developments
Table 86. Ferring Pharmaceuticals Company Details
Table 87. Ferring Pharmaceuticals Business Overview
Table 88. Ferring Pharmaceuticals Microsphere Drug Product
Table 89. Ferring Pharmaceuticals Revenue in Microsphere Drug Business (2018-2024) & (US$ Million)
Table 90. Ferring Pharmaceuticals Recent Developments
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Microsphere Drug Product
Table 94. AstraZeneca Revenue in Microsphere Drug Business (2018-2024) & (US$ Million)
Table 95. AstraZeneca Recent Developments
Table 96. Pfizer Company Details
Table 97. Pfizer Business Overview
Table 98. Pfizer Microsphere Drug Product
Table 99. Pfizer Revenue in Microsphere Drug Business (2018-2024) & (US$ Million)
Table 100. Pfizer Recent Developments
Table 101. AbbVie Company Details
Table 102. AbbVie Business Overview
Table 103. AbbVie Microsphere Drug Product
Table 104. AbbVie Revenue in Microsphere Drug Business (2018-2024) & (US$ Million)
Table 105. AbbVie Recent Developments
Table 106. Beijing Biote Pharmaceutical Co.,Ltd Company Details
Table 107. Beijing Biote Pharmaceutical Co.,Ltd Business Overview
Table 108. Beijing Biote Pharmaceutical Co.,Ltd Microsphere Drug Product
Table 109. Beijing Biote Pharmaceutical Co.,Ltd Revenue in Microsphere Drug Business (2018-2024) & (US$ Million)
Table 110. Beijing Biote Pharmaceutical Co.,Ltd Recent Developments
Table 111. Livzon Pharmaceutical Group Company Details
Table 112. Livzon Pharmaceutical Group Business Overview
Table 113. Livzon Pharmaceutical Group Microsphere Drug Product
Table 114. Livzon Pharmaceutical Group Revenue in Microsphere Drug Business (2018-2024) & (US$ Million)
Table 115. Livzon Pharmaceutical Group Recent Developments
Table 116. Luye Pharma Company Details
Table 117. Luye Pharma Business Overview
Table 118. Luye Pharma Microsphere Drug Product
Table 119. Luye Pharma Revenue in Microsphere Drug Business (2018-2024) & (US$ Million)
Table 120. Luye Pharma Recent Developments
Table 121. Grand Pharmaceutical Group Limited Company Details
Table 122. Grand Pharmaceutical Group Limited Business Overview
Table 123. Grand Pharmaceutical Group Limited Microsphere Drug Product
Table 124. Grand Pharmaceutical Group Limited Revenue in Microsphere Drug Business (2018-2024) & (US$ Million)
Table 125. Grand Pharmaceutical Group Limited Recent Developments
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Microsphere Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Microsphere Drug Market Share by Type: 2022 VS 2034
Figure 3. Leuprolide Microspheres Features
Figure 4. Risperidone Microspheres Features
Figure 5. Octreotide Microspheres Features
Figure 6. Triptorelin Microspheres Features
Figure 7. other Features
Figure 8. Global Microsphere Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Microsphere Drug Market Share by Application: 2022 VS 2034
Figure 10. Cancer Case Studies
Figure 11. Mental Illness Case Studies
Figure 12. Other Case Studies
Figure 13. Microsphere Drug Report Years Considered
Figure 14. Global Microsphere Drug Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 15. Global Microsphere Drug Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 16. Global Microsphere Drug Market Share by Region: 2022 VS 2034
Figure 17. Global Microsphere Drug Market Share by Players in 2022
Figure 18. Global Top Microsphere Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microsphere Drug as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Microsphere Drug Revenue in 2022
Figure 20. North America Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. North America Microsphere Drug Market Share by Type (2018-2034)
Figure 22. North America Microsphere Drug Market Share by Application (2018-2034)
Figure 23. North America Microsphere Drug Market Share by Country (2018-2034)
Figure 24. United States Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Canada Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Europe Microsphere Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 27. Europe Microsphere Drug Market Share by Type (2018-2034)
Figure 28. Europe Microsphere Drug Market Share by Application (2018-2034)
Figure 29. Europe Microsphere Drug Market Share by Country (2018-2034)
Figure 30. Germany Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. France Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. U.K. Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Italy Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Russia Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Nordic Countries Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. China Microsphere Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 37. China Microsphere Drug Market Share by Type (2018-2034)
Figure 38. China Microsphere Drug Market Share by Application (2018-2034)
Figure 39. Asia Microsphere Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 40. Asia Microsphere Drug Market Share by Type (2018-2034)
Figure 41. Asia Microsphere Drug Market Share by Application (2018-2034)
Figure 42. Asia Microsphere Drug Market Share by Region (2018-2034)
Figure 43. Japan Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. South Korea Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. China Taiwan Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Southeast Asia Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. India Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Australia Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Microsphere Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Microsphere Drug Market Share by Type (2018-2034)
Figure 51. Middle East, Africa, and Latin America Microsphere Drug Market Share by Application (2018-2034)
Figure 52. Middle East, Africa, and Latin America Microsphere Drug Market Share by Country (2018-2034)
Figure 53. Brazil Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 54. Mexico Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. Turkey Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. Saudi Arabia Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 57. Israel Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 58. GCC Countries Microsphere Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 59. Johnson & Johnson Revenue Growth Rate in Microsphere Drug Business (2018-2024)
Figure 60. Takeda Revenue Growth Rate in Microsphere Drug Business (2018-2024)
Figure 61. Novartis Revenue Growth Rate in Microsphere Drug Business (2018-2024)
Figure 62. Ipsen Biopharmaceuticals, Inc Revenue Growth Rate in Microsphere Drug Business (2018-2024)
Figure 63. Ferring Pharmaceuticals Revenue Growth Rate in Microsphere Drug Business (2018-2024)
Figure 64. AstraZeneca Revenue Growth Rate in Microsphere Drug Business (2018-2024)
Figure 65. Pfizer Revenue Growth Rate in Microsphere Drug Business (2018-2024)
Figure 66. AbbVie Revenue Growth Rate in Microsphere Drug Business (2018-2024)
Figure 67. Beijing Biote Pharmaceutical Co.,Ltd Revenue Growth Rate in Microsphere Drug Business (2018-2024)
Figure 68. Livzon Pharmaceutical Group Revenue Growth Rate in Microsphere Drug Business (2018-2024)
Figure 69. Luye Pharma Revenue Growth Rate in Microsphere Drug Business (2018-2024)
Figure 70. Grand Pharmaceutical Group Limited Revenue Growth Rate in Microsphere Drug Business (2018-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries